Role of psychological factor on Anemia and comparison of management between standrard Ayurveda treatment and add on effect of relaxation technique with standard Ayurveda treatment

â??A case control study on etiopathogenic role of Pandurogokta Manasa Hetu in Iron Deficiency Anemia and a randomized comparative clinical trial on the Upashayatamaka effect of relaxation technique with standard Ayurveda treatment.â??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052549

Enrollment

127

Registered

2023-05-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria Part I - Cases • Patient of either sex of age between 18 â?? 45 years, willing to participate from OPD of AIIA. • Newly diagnosed cases of anemia with a hemoglobin level less than 12 gm/dl in females and 13 gm/dl in males as per WHO criteria. • Serum ferritin level below 15 mg /dl36. Part I - Controls • Healthy volunteers of either sex with age between 18 â?? 45 years coming to the AIIA. • With hemoglobin levels of females greater than 12.0 gm/dl, and males greater than 13.0 gm/dl41. • No history of any disease for the past 6 months Part II (Inclusion criteria of cases for interventional study) • Hemoglobin Level between 7 - 12 gm % i.e., mild to moderate cases of IDA. • Rest as per inclusion criteria of Part - I

Exclusion criteria

Exclusion criteria: Exclusion criteria: • Other coexisting nutritional deficiency anemias. • Therapeutic-induced anemia (ex. Ibuprofen, NSAIDâ??s, Aspirin). • Anemia of chronic inflammation / systemic disease (ex. Tuberculosis, Rheumatoid Arthritis, Diabetes mellitus). • Identifiable source of blood loss. • Parasitic infestation. • Hemolytic anemias. • Patients having coagulopathies or on anticoagulant therapy. • Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
improvement of hemoglobin, and serum ferritin level in IDA patient by 30 days intervention Timepoint: 4 weeks.	—

Secondary

Measure	Time frame
â?¢To assess the status of Agni in IDA patients in both trial arms at the end of 30 days intervention â?¢ To compare the effect of standard Ayurveda Pandu roga treatment with or without relaxation techniques on CBC, and serum ferritin levels in IDA patients at the end of 30 days intervention (Part II of the Study). â?¢ To assess both trial arms of IDA Patients on Pandurogokta manasa hetu questionnaire at the end of 30 days of intervention. Timepoint: after 30 days of intervention	—

Measure

Time frame

â?¢To assess the status of Agni in IDA patients in both trial arms at the end of 30 days intervention â?¢ To compare the effect of standard Ayurveda Pandu roga treatment with or without relaxation techniques on CBC, and serum ferritin levels in IDA patients at the end of 30 days intervention (Part II of the Study). â?¢ To assess both trial arms of IDA Patients on Pandurogokta manasa hetu questionnaire at the end of 30 days of intervention. Timepoint: after 30 days of intervention

—

Countries

India

Contacts

Public ContactNalini saini

All India Institute of Ayurveda, Sarita Vihar, New Delhi, 110076

vd.raishalini@gmail.com06395865670

Outcome results